T.-Z. Zhang et al. / Tetrahedron: Asymmetry 18 (2007) 1990–1994
1993
4.2.4. Ethyl 2-[(tert-butoxycarbonyloxy)(40-methoxyphen-
yl)methyl]acrylate 1d. Yield: 18%; H NMR (300 MHz,
ative intensity %): 367 (M+ <1), 334 (7), 147 (50), 104 (57),
76 (100), 50 (39).
1
CDCl3) d 7.32 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.7 Hz,
2H), 6.42 (s, 1H), 6.38 (s, 1H), 5.90 (s, 1H), 4.16–4.12 (m,
2H), 3.79 (s, 3H), 1.46 (s, 9H), 1.22 (t, J = 7.4 Hz, 3H);
13C NMR (CDCl3, 75 MHz) d 164.9, 159.6, 152.4, 139.9,
129.5, 129.2, 124.8, 113.7, 82.4, 75.6, 60.8, 55.2, 27.7,
14.0; ESI-MS m/z: 359 [M++Na+], 391 [M++MeOH+-
Na+]. IR (KBr): 2981, 1747, 1613, 1515, 1251, 1159,
1034, 966, 885 cmꢀ1; HRMS (MALDI): Anal. Calcd for
C18H24O6Na+: 359.1468. Found: 359.1465.
4.3.5. N-[2-(Ethoxycarbonyl)-1-(40-nitrophenyl)allyl]-phthal-
imide 3ba. Yield: 78%; ee: 29% by HPLC Chiralcel OD-H
column with hexane/isopropanol = 85:15, flow rate =
0.7 mL/min, tR1 = 17.29 min, tR2 = 20.88 min; 1H NMR
(300 MHz, CDCl3) d 8.22 (d, J = 8.9 Hz, 2H), 7.89–7.75
(m, 4H), 7.63 (d, J = 8.5 Hz, 2H), 6.64 (s, 1H), 6.52 (s,
1H), 5.63 (m, 1H), 4.18–4.14 (m, 2H), 1.18 (t, J = 7.4 Hz,
3H); 13C NMR (CDCl3, 75 MHz) d 167.6, 165.0, 147.5,
144.2, 136.5, 134.4, 134.3, 131.5, 129.7, 123.8, 123.6, 61.4,
53.7, 13.9; MALDI-MS m/z: 403 [M++Na+]; IR (KBr):
2925, 1717, 1521, 1348, 856, 721, 531 cmꢀ1; HRMS (MAL-
DI): Anal. Calcd for C20H16N2O6Na+: 403.09000. Found:
403.09006.
4.3. General procedure for asymmetric allylic nucleophilic
substitution of Morita–Baylis–Hillman adducts
To a reaction vessel charged with substrate 1 (0.5 mmol),
phthalimide 2 or 2-trimethylsilyloxy furan 6 (1 mmol),
and (R)-[2.2]paracyclophane monophosphine 4e (0.1
mmol), was added THF (1.6 mL). The reaction was al-
lowed to stir at room temperature until complete consump-
tion of substrate, at that point the reaction mixture was
evaporated onto silica gel and the product was purified
by silica gel chromatography.
4.3.6.
N-[2-tert-Butoxycarbonyl-1-(40-nitrophenyl)allyl]-
phthalimide 3bb. Yield: 82%; ee: 21% by HPLC Chiralcel
OD-H column with hexane/isopropanol = 85:15, flow
rate = 0.7 mL/min, tR1 = 13.63 min, tR2 = 21.96 min; 1H
NMR (300 MHz, CDCl3) d 8.21 (d, J = 8.9 Hz, 2H), 7.87
(m, 2H), 7.75 (m, 2H), 7.62 (d, J = 8.7 Hz, 2H), 6.52 (s,
1H), 6.44 (s, 1H), 5.50 (s, 1H), 1.34 (s, 9H); 13C NMR
(CDCl3, 75 MHz) d 167.5, 164.0, 147.4, 144.5, 137.9,
134.4, 131.5, 129.7, 128.3, 123.6, 81.9, 53.9, 27.7; EI-MS
m/z (relative intensity %): 334 (15), 306 (12), 188 (7), 57
4.3.1. N-[(2-Methoxycarbonyl-1-phenyl)allyl]-phthalimide
3a.5a Yield: 80%; ee: 52% by HPLC Chiralcel OD-H col-
umn with hexane/isopropanol = 70:30, flow rate = 0.6 mL/
min, tR1 = 7.29 min, tR2 = 13.40 min; 1H NMR (300 MHz,
CDCl3) d 7.85–7.81 (m, 2H), 7.72–7.69 (m, 2H), 7.45–7.30
(m, 5H), 6.56 (s, 1H), 6.39 (s, 1H), 5.63 (s, 1H), 3.70 (s, 3H);
ESI-MS m/z: 322 [M++1], 339 [M++H2O].
(100). IR (KBr): 2928, 1727, 1523, 1348, 1148, 722 cmꢀ1
;
HRMS (MALDI): Anal. Calcd for C22H20N2O6Na+:
431.1216. Found: 431.1214.
4.3.7. N-[2-Methoxycarbonyl-1-(40-chlorophenyl)allyl]-phthal-
imide 3c. Yield: 85%; ee: 37% by HPLC Chiralcel OD-H
column with hexane/isopropanol = 85:15, flow rate =
0.6 mL/min, tR1 = 8.48 min, tR2 = 12.10 min; 1H NMR
(300 MHz, CDCl3) d 7.85–7.71 (m, 4H), 7.40–7.27 (m,
4H), 6.57 (s, 1H), 7.37 (s, 1H), 5.64 (s, 1H), 3.70 (s, 3H);
ESI-MS m/z: 499 [M++MeOH+Na+]. IR (KBr): 2924,
1724, 1492, 1385, 1089, 723 cmꢀ1; HRMS (MALDI): Anal.
Calcd for C19H14NO4ClNa+: 378.0509. Found: 378.0504.
4.3.2.
N-[(2-Ethoxycarbonyl-1-phenyl)allyl]-phthalimide
3ab. Yield: 68%; ee: 66% by HPLC Chiralpak AD-H col-
umn with hexane/isopropanol = 87:13, flow rate = 0.7 mL/
min, tR1 = 19.39 min, tR2 = 22.14 min; 1H NMR
(300 MHz, CDCl3) d 7.83 (m, 2H), 7.70 (m, 2H), 7.45–
7.30 (m, 5H), 6.56 (s, 1H), 6.37 (s, 1H), 5.80 (s, 1H),
4.16–4.10 (m, 2H), 1.14 (t, J = 6.8 Hz, 3H); EI-MS m/z
(relative intensity %): 335 (M++5), 289 (100), 261 (90),
233 (55).
4.3.8.
N-[2-Ethoxycarbonyl-1-(40-methoxyphenyl)allyl]-
4.3.3. N-[(2-tert-Butoxycarbonyl-1-phenyl)allyl]-phthalimide
3ac. Yield: 75%; ee: 44% by HPLC Chiralpak AD-H col-
umn with hexane/isopropanol = 85:15, flow rate = 0.6 mL/
min, tR1 = 7.46 min, tR2 = 11.23 min; 1H NMR (300 MHz,
CDCl3) d 7.85–7.70 (m, 4H), 7.46–7.31 (m, 5H), 6.46 (s,
1H), 6.31 (s, 1H), 5.44 (s, 1H), 1.31 (s, 9H); 13C NMR
(CDCl3, 75 MHz) d 167.8, 164.7, 139.2, 137.4, 134.0,
131.8, 128.8, 128.5, 128.0, 123.3, 81.4, 54.9, 27.8; EI-MS
m/z (relative intensity %): 307 (23), 289 (80), 261 (100),
233 (37). IR (KBr): 2978, 1721, 1386, 1251, 1145, 721,
531 cmꢀ1; HRMS (MALDI): Anal. Calcd for C22H21NO4-
Na+: 386.1362. Found: 386.1363.
phthalimide 3d. Yield: 60%; ee: 48% by HPLC Chiralcel
OD-H column with hexane/isopropanol = 85:15, flow
rate = 0.6 mL/min, tR1 = 10.98 min, tR2 = 14.28 min; 1H
NMR (300 MHz, CDCl3) d 7.83–7.68 (m, 4H), 7.39 (d,
J = 8.6 Hz, 2H), 6.86 (d, J = 9.0 Hz, 2H), 6.53 (s, 1H),
6.32 (s, 1H), 5.59 (s, 1H), 4.14–4.10 (m, 2H), 1.14 (t, J =
7.0 Hz, 3H); ESI-MS m/z: 388 [M++Na+], 420
[M++MeOH+Na+]. IR (KBr): 2962, 1514, 1259, 1028,
716 cmꢀ1; HRMS (MALDI): Anal. Calcd for C21H19NO5-
Na+: 388.1144. Found: 388.1155.
4.3.9. N-[(2-Methoxycarbonyl-1-ethyl)allyl]-phthalimide 3e.
Yield: 44%; ee: 9% by HPLC Chiralcel OD-H column with
hexane/isopropanol = 85:15, flow rate = 0.6 mL/min,
tR1 = 6.92 min, tR2 = 8.33 min; 1H NMR (300 MHz,
CDCl3) d 7.84–7.81 (m, 2H), 7.73–7.69 (m, 2H), 6.54 (s,
1H), 6.08 (s, 1H), 5.18–5.12 (m, 1H), 3.73 (s, 3H), 0.97–
0.83 (m, 5H); ESI-MS m/z: 296 [M++Na+], 328
[M++MeOH+Na+]. IR (KBr): 2965, 1725, 1386, 1260,
4.3.4. N-[2-Methoxycarbonyl-1-(40-nitrophenyl)allyl]-phtha-
limide 3b.5a Yield: 95%; ee: 71% HPLC Chiralcel OD-H
column
with
hexane/isopropanol = 85:15,
flow
rate = 0.7 mL/min, tR1 = 19.50 min, tR2 = 23.43 min; 1H
NMR (300 MHz, CDCl3) d 8.20 (d, J = 8.9 Hz, 2H), 7.85
(m, 2H), 7.75 (m, 2H), 7.60 (d, J = 9.0 Hz, 2H), 6.63 (s,
1H), 6.52 (s, 1H), 5.66 (s, 1H), 3.72 (s, 3H); EI-MS m/z (rel-